Extended Injection Intervals after Switching from Ranibizumab to Aflibercept in Macular Edema due to Central Retinal Vein Occlusion

PURPOSE: To assess treatment interval extension after switching from ranibizumab to aflibercept intravitreal injections in macular edema (ME) due to central retinal vein occlusion (CRVO) with an insufficient response or frequent recurrences to initial treatment. METHODS: CRVO eyes treated with ranib...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Ophthalmol
Asıl Yazarlar: Nghiem-Buffet, Sylvia, Glacet-Bernard, Agnès, Addou-Regnard, Manar, Souied, Eric H., Cohen, Salomon Y., Giocanti-Auregan, Audrey
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Hindawi 2018
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6079418/
https://ncbi.nlm.nih.gov/pubmed/30116635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8656495
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller